Vancomycin: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Robert Badgett
(Added External links)
imported>Robert Badgett
No edit summary
Line 1: Line 1:
==Pharmacology==
The half life in normal individuals is 4-6 hours.<ref name="DailyMed-Vancomycin">{{cite web |url=http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=3625 |title=vancomycin hydrochloride (Vancomycin Hydrochloride)  injection, solution|author=DailyMed|accessdate=2008-01-06 |format= |work=}}</ref>
==Adverse effects==
==Adverse effects==
===Thrombocytopenia===
===Thrombocytopenia===

Revision as of 12:00, 6 January 2008

Pharmacology

The half life in normal individuals is 4-6 hours.[1]

Adverse effects

Thrombocytopenia

Vancomycin may cause immune thrombocytopenia.[2]

Acute kidney injury

Vancomycin is associated with acute kidney injury if trough levels are above 15 microg/mL.[3] To avoid this, the blood levels of vancomycin should be monitored.[4][5]

References

  1. DailyMed. vancomycin hydrochloride (Vancomycin Hydrochloride) injection, solution. Retrieved on 2008-01-06.
  2. Von Drygalski A, Curtis BR, Bougie DW, et al (2007). "Vancomycin-induced immune thrombocytopenia". N. Engl. J. Med. 356 (9): 904–10. DOI:10.1056/NEJMoa065066. PMID 17329697. Research Blogging.
  3. Hidayat LK, Hsu DI, Quist R, Shriner KA, Wong-Beringer A (2006). "High-dose vancomycin therapy for methicillin-resistant Staphylococcus aureus infections: efficacy and toxicity". Arch. Intern. Med. 166 (19): 2138–44. DOI:10.1001/archinte.166.19.2138. PMID 17060545. Research Blogging.
  4. Welty TE, Copa AK (1994). "Impact of vancomycin therapeutic drug monitoring on patient care". Ann Pharmacother 28 (12): 1335–9. PMID 7696720[e]
  5. Iwamoto T, Kagawa Y, Kojima M (2003). "Clinical efficacy of therapeutic drug monitoring in patients receiving vancomycin". Biol. Pharm. Bull. 26 (6): 876–9. PMID 12808304[e]

External links

for injection 3625 - FDA approved drug information (drug label) from DailyMed (U.S. National Library of Medicine).